Genetic influences in experimental pancreatitis

描述（由申请人提供）： 胰腺炎是胰腺的急性或慢性炎症性疾病，在美国和美国退伍军人人群中导致显著的发病率和死亡率。过去几十年的趋势显示，美国人群中胰腺炎的发病率增加。大多数急性胰腺炎病例与酒精或胆结石有关。慢性胰腺炎导致进行性纤维化和实质丧失，通常继发于急性炎症的反复发作，酒精滥用是主要的促发因素。广泛的努力一直致力于了解胰腺损伤的原因和机制，但是，有非常有限的知识有关的作用，遗传学改变的易感性和进展的急性和慢性胰腺炎。酒精性胰腺炎在男性和非裔美国人中的患病率较高，这表明酒精性胰腺炎的遗传易感性。酒精性胰腺炎的发病机制的明确理解一直受到实验模型的有限性的阻碍。然而，有几种小鼠胰腺炎模型可用，研究最多的是雨蛙肽给药，其可引起急性和慢性胰腺炎，并且如果与乙醇一起给药则具有协同作用。我们的假设是，可以确定遗传修饰剂，促进或改善胰腺炎的程度，这些修饰剂作为潜在的治疗靶点。这一假设得到了重要的初步结果和出版物记录的支持，将通过以下方式进行检验：（i）鉴定对急性和慢性实验性胰腺炎敏感或耐药的小鼠品系（目标1和2）;（二）利用目标1和2的小鼠品系，同时采用蛋白质组学和基因组学方法，确定与实验性胰腺炎易感性或耐药性相关的分子途径（目标3）;和（iii）测试通过肝素靶向凝血途径作为实验性胰腺炎的治疗方式的效果（目的4）。我们的目标的完成应显着提高我们有限的知识，关于实验性胰腺炎的遗传修饰，并提供有关凝血途径作为治疗靶点的效用的见解。实验模型中的发现可以在人类胰腺炎中进行测试，并可能导致潜在的新治疗方法。

DESCRIPTION (provided by applicant): Pancreatitis, an acute or chronic inflammatory disease of the pancreas, results in significant morbidity and mortality in the United States and within our US veteran population. Trends over the past few decades show an increased incidence of pancreatitis in the US population. The majority of acute pancreatitis cases are related to alcohol or gallstones. Chronic pancreatitis, which results in progressive fibrosis and loss of parenchyma, is generally secondary to recurrent episodes of acute inflammation with alcohol abuse being a major precipitating factor. Extensive efforts have been dedicated to understanding the causes and mechanisms of pancreatic injury; however, there is very limited knowledge pertaining to the role of genetics in modifying the susceptibility and progression of acute and chronic pancreatitis. A genetic predisposition to alcohol-induced pancreatitis is suggested by its higher prevalence in males as well as in African Americans. A clear understanding of the pathogenesis of alcoholic pancreatitis has been hindered by the limited availability of experimental models. However, several mouse pancreatitis models are available, with the most studied being cerulein administration which can cause acute and chronic pancreatitis and has a synergistic effect if given with ethanol. Our hypothesis is that genetic modifiers can be identified that promote or ameliorate the extent of pancreatitis, and such modifiers serve as potential therapeutic targets. This hypothesis, which is supported by significant preliminary results and publication record, will be tested by: (i) Identifying mouse strains that are susceptible or resistant to acute and chronic experimental pancreatitis (Aims 1 and 2); (ii) Utilizing the mouse strains from Aims 1 and 2, together with proteomic and genomic approaches, to identify molecular pathways that associate with susceptibility or resistance to experimental pancreatitis (Aim 3); and (iii) Testing the effect of targeting the coagulation pathway, via heparin, as a therapeutic modality in experimental pancreatitis (Aim 4). Completion of our aims should markedly improve our limited knowledge regarding genetic modifiers of experimental pancreatitis and provide insights regarding the utility of the coagulation pathway as a treatment target. Findings in the experimental models can then be tested in human pancreatitis, and may lead to potential novel therapeutic approaches.